Pyrrolobenzodiazepines used to treat proliferative diseases

Details for Australian Patent Application No. 2011239525 (hide)

Owner Seattle Genetics, Inc. Spirogen Developments SARL

Inventors Howard, Philip Wilson; Masterson, Luke; Tiberghien, Arnaud; Jeffrey, Scott; Burke, Patrick; Senter, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2011239525

PCT Pub. Number WO2011/130616

Priority 61/324,453 15.04.10 US

Filing date 15 April 2011

Wipo publication date 20 October 2011

International Classifications

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/5517

A61P 35/00 Antineoplastic agents

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/130616 Priority application(s): WO2011/130616

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239545-Reduced-pressure sources, systems, and methods employing a polymeric, porous, hydrophobic material

2011239522-Targeted pyrrolobenzodiazapine conjugates